Ameritas Advisory Services, LLC Amgen Inc Transaction History

Ameritas Advisory Services, LLC

$2.24 Billion
Q3 2024

A detailed history of Ameritas Advisory Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 6,512 shares of AMGN stock, worth $1.72 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,512

Previous 9,432 30.96%

Holding current value

$1.72 Million

Previous $2.95 Million 28.81%

% of portfolio

0.09%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $903,389 - $985,149	-2,920 Reduced 30.96%	6,512 $2.1 Million
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $104,837 - $127,404	399 Added 4.42%	9,432 $2.95 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $942,927 - $1.14 Million	3,507 Added 63.46%	9,033 $2.57 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $779,885 - $879,802	-3,050 Reduced 35.56%	5,526 $1.59 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $713,236 - $885,502	3,262 Added 61.39%	8,576 $2.3 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $286,907 - $339,262	-1,339 Reduced 20.13%	5,314 $1.18 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $123,281 - $150,259	-546 Reduced 7.58%	6,653 $1.61 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $111,079 - $141,139	485 Added 7.22%	7,199 $1.89 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $7,407 - $8,353	33 Added 0.49%	6,714 $1.51 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $35,298 - $39,281	153 Added 2.34%	6,681 $1.63 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $78,937 - $87,325	360 Added 5.84%	6,528 $1.58 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $1.23 Million - $1.4 Million	6,168 New	6,168 $1.39 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.

Account

Ameritas Advisory Services, LLC Amgen Inc Transaction History